Roivant Sciences (NASDAQ:ROIV) Earns Buy Rating from HC Wainwright
Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $18.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 59.29% from the company’s previous close. Separately, Cantor Fitzgerald raised Roivant […]
Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $18.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 59.29% from the company’s previous close. Separately, Cantor Fitzgerald raised Roivant […]
